• English
  • Español
  • CONTACT US
  • HOME
ONCOMATRYX

ONCOMATRYX

pioneering stromal medicine

Menu

  • ABOUT
    • TARGETING TUMOR STROMA
    • LEADERSHIP
    • SCIENTIFIC ADVISORY BOARD
    • COLLABORATIONS
    • PUBLICATIONS
  • DRUG DISCOVERY
    • PRECISION DRUGS
    • ANTIBODY DRUG CONJUGATES
      • ADC OMTX705
      • ADC OMTX703
    • PIPELINE
  • DIAGNOSTICS
    • COL11A1 BIOMARKER
    • INVASIVE TUMOR DIAGNOSTICS -invaScan-
    • BLADDER CANCER DIAGNOSTICS -bladderScan-
  • COMPANION DX
    • COMPANION DIAGNOSTICS
  • BLOG
    • TEAM POSTS
    • NEWS
    • PRESS Releases
    • VIDEO
  • CONTACT
    • CONTACT US
    • CAREERS
    • NEXT EVENT

Author: Oncomatryx

“I declare war on cancer stroma”

“I declare war on cancer stroma”

LAUREANO SIMON, Oncomatryx CEO, declares war on tumor microenvironment. “We envision a new era where cancer in general and invasive tumors in particular will be beaten with orchestrated combinations of precision

Oncomatryx2022-05-302022-03-09 VIDEO Read more

Poster Presentation at ESMO 2018 Congress

Poster Presentation at ESMO 2018 Congress

ESMO 2018 Congress Munich, Germany – 19 Oct – 23 Oct 2018 Myriam Fabre, PhD. (Oncomatryx R&D Director) presents the poster: OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with

Oncomatryx2018-10-032019-10-11 NEWS No Comments Read more

Oncomatryx at BIO EUROPE SPRING 2018

Oncomatryx at BIO EUROPE SPRING 2018

Oncomatryx will attend BIO EUROPE SPRING 2018, the essential appointment in biotechnology BIO EUROPE SPRING 2018 March 12-14, 2018 Amsterdam, The Netherlands https://ebdgroup.knect365.com/bioeurope- If you are also attending this event and you would like

Oncomatryx2018-02-012019-10-11 NEWS No Comments Read more

Oncomatryx at BIO 2017 (San Diego)

Oncomatryx at BIO 2017 (San Diego)

Oncomatryx will attend BIO 2017, the Global Event for Biotechnology.  

Oncomatryx2017-04-282019-10-11 NEWS No Comments Read more

Oncomatryx events in March

Oncomatryx events in March

ENTURE SUMMIT WEST 2017 February 28 – March 1 2017 Mountain View, CA USA David Raksin, our Business Development Director will be a Presenting role as a Top Innovator in

Oncomatryx2017-02-102019-10-11 NEWS No Comments Read more

Antibody Drug Conjugates, the beginning of the end?

Antibody Drug Conjugates, the beginning of the end?

  Antibody Drug Conjugates Against Tumor Stroma: The Beginning of The End? by Mirella Zulueta, Business Development Director at Oncomatryx   The potential of a technology trigger Despite many research breakthroughs

Oncomatryx2016-11-122019-10-11 TEAM POSTS No Comments Read more

Oncomatryx at BioEurope 2016

Oncomatryx at BioEurope 2016

Oncomatryx will attend BIOEUROPE. November 7-9. Cologne. FOCUS. November 9-12. Cyprus.   If you are also attending any of these events and you would like to meet us please fill

Oncomatryx2016-09-192016-11-03 NEWS No Comments Read more

Oncomatryx at the “Cancer Metabolism and the Tumour Microenvironment Conference”.

Oncomatryx at the “Cancer Metabolism and the Tumour Microenvironment Conference”.

Oncomatryx at the “Cancer Metabolism and the Tumour Microenvironment Conference”. 9-12, November. Paphos, Cyprus. Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the conference as speaker: TARGETING TUMOR MICROENVIRONMENT TO

Oncomatryx2016-08-032016-08-03 NEWS No Comments Read more

#BIO2016: June 6-9, 2016 in San Francisco

#BIO2016: June 6-9, 2016 in San Francisco
Oncomatryx at BIO 2016. June 6-9. San Francisco. If you are also attending Bio convention and would like to meet us please fill this form to arrange an appointment. Your Name (required) Your Email
Oncomatryx2016-04-292016-04-29 NEWS No Comments Read more

New publication at the ASPIC 2016

New publication at the ASPIC 2016

Poster presentation at the 2nd ASPIC  International Congress. 28-29 April, 2016. Porto. Portugal. We are pleased to inform you that Enrique De Alava team from Hospital Virgen del Rocío, Sevilla, Spain,

Oncomatryx2016-04-222016-04-22 NEWS No Comments Read more
  • « Previous

Archives

  • May 2023
  • September 2022
  • May 2022
  • March 2022
  • November 2020
  • October 2018
  • February 2018
  • April 2017
  • February 2017
  • November 2016
  • September 2016
  • August 2016
  • April 2016
  • February 2016
  • December 2015
  • July 2015
  • May 2015
  • June 2013
  • January 2013

Meta

  • Log in

UE Next Generation

PRECISION DRUGS

  • PRECISION DRUGS
  • ANTIBODY DRUG CONJUGATES
  • PIPELINE

DIAGNOSTICS

  • COL11A1 BIOMARKER
  • INVASIVE TUMOR DIAGNOSTICS -invaScan-
  • BLADDER CANCER DIAGNOSTICS -bladderScan-

With the collaboration of:

ONCOMATRYX BIOPHARMA SL ©2019
  • English
  • Español
  • TERMS OF USE
  • PRIVACY POLICY
  • SITE MAP